145 results
Page 5 of 8
8-K/A
EX-99.1
qloy0yl4r cvae4mxi
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
8win9ezxe8c 2b
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
2tsw3x bn
7 Jan 19
Other Events
7:40am
8-K
hgza2a0u
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
9pae cl811jf
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
shsz820
22 Oct 18
Other Events
8:38am
8-K
5bhng
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
klir68fm
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
ljju15in9sd26oqp6v
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
6p2c5t0s r3yvu
18 Jul 18
Other Events
5:01pm
8-K
EX-99.1
x0enmn8s9n4y dyjf
18 Jul 18
Other Events
5:01pm
S-3ASR
k3rwy7k65 q0jobw5
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
s3do3c9ct
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am